Spastin in the human and mouse central nervous system with special reference to its expression in the hippocampus of mouse pilocarpine model of status epilepticus and temporal lobe epilepsy

Neurochemistry International

Volumn 49, Issue 7, 2006, Pages 651-664

  Ma, Dong Liang ^a,e   Chia, Shwn Chin ^a   Tang, Yong Cheng ^a   Chang, May Ling Joyce ^a   Probst, Alphonse ^b   Burgunder, Jean Marc ^c,d   Tang, Feng Ru ^a,c  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b UNIVERSITY OF BASEL   (Switzerland)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF BERN   (Switzerland)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Central nervous system; Distribution; Epilepsy; Hippocampus; Human; Mouse; Spastin

Indexed keywords

MESSENGER RNA; PILOCARPINE; SPASTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; CRANIAL NERVE; CYTOPLASM; DENDRITE; DENTATE NUCLEUS; DOWN REGULATION; ENTORHINAL CORTEX; EPILEPTIC STATE; EPILEPTOGENESIS; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOTONEURON NUCLEUS; MOUSE; NERVE ENDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; PYRIFORM CORTEX; SUBSTANTIA NIGRA; TEMPORAL LOBE EPILEPSY; THALAMUS NUCLEUS; TISSUE DISTRIBUTION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ASTROCYTES; BRAIN; CONVULSANTS; DENTATE GYRUS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPILEPSY; EPILEPSY, TEMPORAL LOBE; GLIOSIS; HIPPOCAMPUS; HUMANS; MALE; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCARINIC AGONISTS; NEURONS; PILOCARPINE; RNA, MESSENGER; SPECIES SPECIFICITY; STATUS EPILEPTICUS;

EID: 33750012332     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.05.008     Document Type: Article

References (36)

1. Arjundas G., Ramamurthi B., and Chettur L. Familial spastic paraplegia (a review with four case reports). J. Assoc. Phys. India 19 (1971) 653-657
2. Beetz C., Brodhun M., Moutzouris K., Kiehntopf M., Berndt A., Lehnert D., Deufel T., Bastmeyer M., and Schickel J. Identification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter system. Biochem. Biophys. Res. Commun. 318 (2004) 1079-1084
3. Bruyn G.W., and Mechelse K. The association of familial spastic paraplegia and epilepsy in one family. Psychiatr. Neurol. Neurochir. 65 (1962) 280-292
4. Burgunder J.M., and Young III W.S. Cortical neurons expressing the cholecystokinin gene in the rat: distribution in the adult brain, ontogeny, and some of their projections. J. Comp. Neurol. 300 (1990) 26-46
5. Charvin D., Cifuentes-Diaz C., Fonknechten N., Joshi V., Hazan J., Melki J., and Betuing S. Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus. Hum. Mol. Genet. 12 (2003) 71-78
6. Claudiani P., Riano E., Errico A., Andolfi G., and Rugarli E.I. Spastin subcellular localization is regulated through usage of different translation start sites and active export from the nucleus. Exp. Cell Res. 309 (2005) 358-369
7. Errico A., Ballabio A., and Rugarli E.I. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum. Mol. Genet. 11 (2002) 153-163
8. Errico A., Claudiani P., D'Addio M., and Rugarli E.I. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum. Mol. Genet. 13 (2004) 2121-2132
9. Evans K.J., Gomes E.R., Reisenweber S.M., Gundersen G.G., and Lauring B.P. Linking axonal degeneration to microtubule remodeling by spastin-mediated microtubule severing. J. Cell Biol. 168 (2005) 599-606
10. Fink J.K. Hereditary spastic paraplegia: the pace quickens. Ann. Neurol. 51 (2002) 669-672
11. Gigli G.L., Diomedi M., Bernardi G., Placidi F., Marciani M.G., Calia E., Maschio M.C., and Neri G. Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder. Am. J. Med. Genet. 45 (1993) 711-716
12. Hazan J., Fonknechten N., Mavel D., Paternotte C., Samson D., Artiguenave F., Davoine C.S., Cruaud C., Durr A., Wincker P., Brottier P., Cattolico L., Barbe V., Burgunder J.M., Prud'homme J.F., Brice A., Fontaine B., Heilig B., and Weissenbach J. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat. Genet. 23 (1999) 296-303
13. Heinzlef O., Paternotte C., Mahieux F., Prud'homme J.F., Dien J., Madigand M., Pouget J., Weissenbach J., Roullet E., and Hazan J. Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J. Med. Genet. 35 (1998) 89-93
14. Kuroda S., Kazahaya Y., Otsuki S., and Takahashi S. Familial spastic paraplegia with epilepsy. Acta Med. Okayama 39 (1985) 113-117
15. McDermott C.J., Grierson A.J., Wood J.D., Bingley M., Wharton S.B., Bushby K.M., and Shaw P.J. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann. Neurol. 54 (2003) 748-759
16. Mead S.H., Proukakis C., Wood N., Crosby A.H., Plant G.T., and Warner T.T. A large family with hereditary spastic paraparesis due to a frame shift mutation of the spastin (SPG4) gene: association with multiple sclerosis in two affected siblings and epilepsy in other affected family members. J. Neurol. Neurosurg. Psychiatry 71 (2001) 788-791
17. Neuwald A.F., Aravind L., Spouge J.L., and Koonin E.V. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9 (1999) 27-43
18. Nielsen J.E., Johnsen B., Koefoed P., Scheuer K.H., Gronbech-Jensen M., Law I., Krabbe K., Norremolle A., Eiberg H., Sondergard H., Dam M., Rehfeld J.F., Krarup C., Paulson O.B., Hasholt L., and Sorensen S.A. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur. J. Neurol. 11 (2004) 817-824
19. Nomura H., Koike F., Tsuruta Y., Iwaki A., and Iwaki T. Autopsy case of autosomal recessive hereditary spastic paraplegia with reference to the muscular pathology. Neuropathology 21 (2001) 212-217
20. Okubo S., Ueda M., Kamiya T., Mizumura S., Terashi A., and Katayama Y. Neurological and neuroradiological progression in hereditary spastic paraplegia with a thin corpus callosum. Acta Neurol. Scand. 102 (2000) 196-199
21. Patel S., and Latterich M. The AAA team: related ATPases with diverse functions. Trends Cell Biol. 8 (1998) 65-71
22. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. (2001), Academic Press, San Diego
23. Reid E., Connell J., Edwards T.L., Duley S., Brown S.E., and Sanderson C.M. The hereditary spastic paraplegia protein spastin interacts with the ESCRT-III complex-associated endosomal protein CHMP1B. Hum. Mol. Genet. 14 (2005) 19-38
24. Skre H. Hereditary spastic paraplegia in western Norway. Clin. Genet. 6 (1974) 165-183
25. Sommerfelt K., Kyllerman M., and Sanner G. Hereditary spastic paraplegia with epileptic myoclonus. Acta Neurol. Scand. 84 (1991) 157-160
26. Strmpell A. Beitrage zur Pathologie des Ruckenmarks. Arch. Psychiatr. Nervenkr. 10 (1880) 676-717
27. Svenson I.K., Ashley-Koch A.E., Gaskell P.C., Riney T.J., Cumming W.J., Kingston H.M., Hogan E.L., Boustany R.M., Vance J.M., Nance M.A., Pericak-Vance M.A., and Marchuk D.A. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am. J. Hum. Genet. 68 (2001) 1077-1085
28. Svenson I.K., Kloos M.T., Jacon A., Gallione C., Horton A.C., Pericak-Vance M.A., Ehlers M.D., and Marchuk D.A. Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia. Neurogenetics 6 (2005) 135-141
29. Tang B.S., Chen X., Zhao G.H., Shen L., Yan X.X., Jiang H., and Luo W. Clinical features of hereditary spastic paraplegia with thin corpus callosum: report of 5 Chinese cases. Chin. Med. J. (Engl.) 117 (2004) 1002-1005
30. Tang F.R., Chia S.C., Chen P.M., Gao H., Lee W.L., Yeo T.S., Burgunder J.M., Probst A., Sim M.K., and Ling E.A. Metabotropic glutamate receptor2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, of rats and mice after pilocarpine-induced status epilepticus. Epilepsy Res. 59 (2004) 167-180
31. Tang F.R., Chia S.C., Zhang S., Chen P.M., Gao H., Liu C.P., Khanna S., and Lee W.L. Glutamate receptor 1 immunopositive neurons in the gliotic CA1 area of the mouse hippocampus after pilocarpine induced status epilepticus. Eur. J. Neursci. 21 (2005) 2361-2374
32. Tang F.R., Lee W.L., Gao H., Chen Y., Loh Y.T., and Chia S.C. Expression of different isoforms of protein kinase C in the rat hippocampus after pilocarpine induced status epilepticus with special reference to CA1 area and the dentate gyrus. Hippocampus 14 (2004) 87-98
33. Webb S., Flanagan N., Callaghan N., and Hutchinson M. A family with hereditary spastic paraparesis and epilepsy. Epilepsia 38 (1997) 495-499
34. Wharton S.B., McDermott C.J., Grierson A.J., Wood J.D., Gelsthorpe C., Ince P.G., and Shaw P.J. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J. Neuropathol. Exp. Neurol. 62 (2003) 1166-1177
35. White K.D., Ince P.G., Lusher M., Lindsey J., Cookson M., Bashir R., Shaw P.J., and Bushby K.M. Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology 55 (2000) 89-94
36. Yih J.S., Wang S.J., Su M.S., Tsai S.C., Lin R.H., Lin K.N., and Liu H.C. Hereditary spastic paraplegia associated with epilepsy, mental retardation and hearing impairment. Paraplegia 31 (1993) 408-411